Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plurion is a regenerative medicine company specializing in the development and commercialization of placental-derived tissue products. The company's primary offerings include the Plurion amnion-chorion membrane and umbilical cord allografts, which are used to promote healing and tissue regeneration in various clinical applications such as wound care, dental surgery, and orthopedics. Plurion utilizes a proprietary processing technology designed to preserve the natural biological properties of the tissue while ensuring safety and sterility. The company's products are distributed through partnerships, notably with Osteogenics Biomedical for dental applications. Plurion is headquartered in Scottsdale, Arizona, and focuses on providing high-quality allografts for surgical and clinical use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plurion.